Multiscale modeling of influenza vaccination strategies for optimal T cell immunity

NIH RePORTER · NIH · U01 · $667,809 · view on reporter.nih.gov ↗

Abstract

Project Summary Current influenza vaccines provide focused antibody-mediated protection against seasonal influenza strains included in the vaccine. However, they do not protect from co-circulating mismatched strains, and, more importantly, fail to provide protection against antigenic shifts that can cause potentially devastating pandemics. This proposal investigates the role of T cell immunity, on both the individual and population levels, in providing broad protection against diverse influenza strains. Animal and human studies showed that T cells can provide strain-transcending protection, resulting in more rapid viral clearance, decreased immunopathology, and improved clinical outcomes, and thus the improvement of strategies to induce protective levels of influenza- specific T cells are of critical importance. However, little is known about the rules for boosting influenza-specific resident memory T cells in the respiratory tract in the face of pre-existing humoral immunity from prior influenza infections or vaccinations. We will use multi-scale immuno-epidemiological methods that link the scales from the dynamics of infection and immunity within individuals to take of vaccination in the face of pre-existing immunity and the spread of infection on the population level. The knowledge gained form this study will help guide future vaccination efforts against influenza viruses to better generate broadly protective T cell immunity within individuals and across the population.

Key facts

NIH application ID
10414951
Project number
5U01HL139483-05
Recipient
EMORY UNIVERSITY
Principal Investigator
JACOB E KOHLMEIER
Activity code
U01
Funding institute
NIH
Fiscal year
2022
Award amount
$667,809
Award type
5
Project period
2018-09-01 → 2024-05-31